FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/29/2025
Back to search
Official data from USPTO
VIVALYX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
VIVALYX
ST13
US500000079379599Class
5, 10, 39, 42
Filing
79379599
Registration
7665491
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
04/03/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 10, 39, 42
Filing date
08/08/2023
Registration date
01/28/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/28/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DE
Examiner
FAUCETTE, MAX CLIFFORD STE
Law office
L70
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Vivalyx GmbH
Representatives
Kristin S. Cornuelle Orrick, Herrington & Sutcliffe LLP
Technical classification
Nice Classes
Class 5Class 10Class 39Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for organ transplantationpreservationrevitalizationengineering and production; pharmaceutical preparations for tissue transplantationpreservationrevitalizationengineering and production; medical preparations for use in organ and tissue transportationpreservationrevitalizationrecovery; medical preparations for use with maintaining and preserving organs outside of the living bodyfor transportationpreservationrevitalizationrecovery; Pharmaceutical preparations for preserving donor organs and tissues; Pharmaceutical preparations for preserving organs and tissues outside of the living body; therapeutic preparations for organspreparations for organ revitalization and recovery; medical preparations for the preservation and revitalization of organs and tissues; medical preparations for maintaining and improving the quality of organs outside of the body; preservation solutions for use in maintaining and preserving donor organs and tissues; preservation solutions for use in maintaining and preserving organs and tissues outside of the living body; biological preparations for the treatment and maintenance of organs and tissues inside or outside bodies; blood substitutes for human or animal use; engineered biological soft tissues of any kind and solid organskidneyliverheartlungpancreas and intestine; pharmaceutical preparations for regenerating tissue
Class 10
Portable medical apparatus for transporting a harvested organ or tissue from a donor to a recipient; temperature controlled portable medical apparatus for transporting a harvested organ or tissue from a donor to a recipient; medical apparatus and instruments for preserving organstissues and body parts; medical apparatus for preserving organs or tissues inside or outside bodies; medical apparatus for the transportation of organs or tissues; medical apparatus and instruments for revitalizing organstissues and body parts; medical apparatus for revitalizing organs or tissues outside bodies
Class 39
Medical transport servicestransportation of organstissues and body parts
Class 42
Research and development in the field of maintenancepreservationrevitalizationtransportation and storage of organs in vivo and ex vivo; medical research and development in the field of perfusion of donor organs; services in relation to maintaining and improving the quality of organs in vivo or ex vivo in the nature of medical and scientific research in the field of organ and tissue preservationrevitalization and recovery; product research and development of 3d technology and processes in relation to 3d printed organ preservation and production; scientific research in the fields of three-dimensional printing; gene therapy research
Publications
History of USPTO decisions and trademark events.
37 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/13/2025
FIMP
FINAL DISPOSITION PROCESSED
08/13/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/28/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/14/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/27/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/27/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/28/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
01/28/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/10/2024
PUBO
PUBLISHED FOR OPPOSITION
12/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/15/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/14/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/14/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/14/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/09/2024
GNFR
FINAL REFUSAL E-MAILED
10/09/2024
CNFR
FINAL REFUSAL WRITTEN
10/09/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/09/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/09/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/15/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/15/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/15/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/15/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/15/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/15/2024
RFNT
REFUSAL PROCESSED BY IB
05/13/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/25/2024
RFRR
REFUSAL PROCESSED BY MPU
04/25/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/10/2024
CNRT
NON-FINAL ACTION WRITTEN
04/09/2024
DOCK
ASSIGNED TO EXAMINER
04/09/2024
MAFR
APPLICATION FILING RECEIPT MAILED
10/03/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/29/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/28/2023
Continuous trademark protection
Get notified about every new filing that threatens VIVALYX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.